ENSYSCE BIOSCIENCES, INC.: cashflow_operating
| Value | {"amount": -1247342, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | ENSYSCE BIOSCIENCES, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:34:05.973304+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/58fc0b63-292b-4e1d-87ff-b97c18582640
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001493152-22-008438Retrieved: 2026-08-19T17:34:05.973304+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001716947/cashflow-operating/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/58fc0b63-292b-4e1d-87ff-b97c18582640
History
- supersedes {"amount": -864439, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} (evidence 0001213900-21-015361)